Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies

…, T Toptan, B Schenk, C Pallas, M Metzler, N Kohmer… - MedRxiv, 2021 - medrxiv.org
Due to numerous mutations in the spike protein, the SARS-CoV-2 variant of concern
Omicron (B.1.1.529) raises serious concerns since it may significantly limit the antibody-mediated …

[HTML][HTML] Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA. 1 and BA. 2 by convalescent and vaccine serum and monoclonal antibodies

…, T Toptan, B Schenk, C Pallas, M Metzler, N Kohmer… - …, 2022 - thelancet.com
Background In recent months, Omicron variants of SARS-CoV-2 have become dominant in
many regions of the world, and case numbers with Omicron subvariants BA.1 and BA.2 …

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays

N Kohmer, S Westhaus, C Rühl, S Ciesek… - Journal of Clinical …, 2020 - Elsevier
Serological SARS-CoV-2 assays are urgently needed for diagnosis, contact tracing and for
epidemiological studies. So far, there is limited data on how recently commercially available, …

[HTML][HTML] The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro

N Kohmer, T Toptan, C Pallas, O Karaca… - Journal of clinical …, 2021 - mdpi.com
Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections, resources for real-time reverse-transcription polymerase chain reaction (…

Clinical performance of different SARS‐CoV‐2 IgG antibody tests

N Kohmer, S Westhaus, C Rühl… - Journal of Medical …, 2020 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) serological assays are
urgently needed for rapid diagnosis, contact tracing, and for epidemiological studies. So far, …

Exposure to BA. 4/5 S protein drives neutralization of Omicron BA. 1, BA. 2, BA. 2.12. 1, and BA. 4/5 in vaccine-experienced humans and mice

…, K Krüger, O Ozhelvaci, K Grikscheit, N Kohmer… - Science …, 2022 - science.org
The SARS-CoV-2 Omicron variant and its sublineages show pronounced viral escape from
neutralizing antibodies elicited by vaccination or prior SARS-CoV-2 variant infection owing to …

[PDF][PDF] Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity

…, O Ozhelvaci, K Grikscheit, S Hoehl, N Kohmer… - Cell Reports, 2023 - cell.com
Evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant has led to the emergence of sublineages with different patterns of neutralizing antibody …

[HTML][HTML] Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies

N Kohmer, C Rühl, S Ciesek, HF Rabenau - Journal of clinical medicine, 2021 - mdpi.com
The plaque reduction neutralization test (PRNT) is a preferred method for the detection of
functional, SARS-CoV-2 specific neutralizing antibodies from serum samples. Alternatively, …

Assessment of SARS-CoV-2 transmission on an international flight and among a tourist group

S Hoehl, O Karaca, N Kohmer, S Westhaus… - JAMA network …, 2020 - jamanetwork.com
This case series assessed a commercial airline flight from Tel Aviv, Israel, to Frankfurt, Germany,
that occurred on March 9th, 2020. Among 102 passengers on a Boeing 737-900 aircraft …

Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro

M Widera, A Wilhelm, S Hoehl, C Pallas, N Kohmer… - MedRxiv, 2021 - medrxiv.org
The IgG1 monoclonal antibody (mAb) bamlanivimab (LY-CoV555) prevents viral attachment
and entry into human cells by blocking attachment to the ACE2 receptor. However, whether …